Buy or sell Quartet stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Quartet Stock
Technology-Enabled behavioral health
About Quartet Stock
Investors
Deerfield Capital Management
F-Prime Capital Partners
PharmEasy, Devoted Health, Benchling, SonderMind, Prime Medicine, Snapdocs, Flywire, Quartet, Caribou Biosciences, Unison Home Ownership Investors
GV
Uber, Robinhood, Jet, Impossible Foods, Lacework, Slack, Snyk, SambaNova Systems, DocuSign, Gusto
Polaris Partners
Freenome, Automattic, Club Factory, OM1, Egnyte, Quartet, Impinj, VeraCode, Xant, Drizly
Funding History
March 2015 | $7.0M |
---|---|
April 2016 | $40.0M |
January 2018 | $45.0M |
June 2019 | $60.0M |
Management
Chief Executive Officer
David Wennberg, MD, MPH
Chief Mental Health Officer
Robert Accordino, MD, MSc
Chief Product Officer
Sarah Donnelly
Chief People Strategy Officer
Ingrid Kessler
Chief Operating Officer
Kevin Kumler
Chief Medical Officer
David Lim, MD, PhD
Chief Revenue Officer
Nancy Powers
Press
Business Insider - Oct, 2 2019
MobiHealthNews - Jun, 17 2019
TechCrunch - Oct, 5 2018
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase